Overview

Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This is an single-blind, single-center, two-period crossover, PK profile study. Each subject will be randomized to one of two treatment sequences. Both treatment sequences will be enrolled concurrently.
Phase:
Phase 1
Details
Lead Sponsor:
Biogen
Treatments:
Dimethyl Fumarate